FDA Approved: PANTOPRAZOLE SODIUM — Supplemental Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Pantoprazole Sodium from Camber Pharmaceuticals, Inc. under ANDA213778.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duodenal Ulcer
• Erosive Esophagitis
• Gastric Ulcer
• Gastroesophageal Reflux Disease
• Zollinger-ellison Syndrome

Drugs mentioned

• Pantoprazole sodium (pantoprazole sodium)

Snippet

SUPPL AP for PANTOPRAZOLE SODIUM (PANTOPRAZOLE SODIUM)